Topoisomerase I inhibition: a new target or new missiles?

Ann Oncol. 1995 Feb;6(2):102-4. doi: 10.1093/oxfordjournals.annonc.a059100.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives*
  • Camptothecin / pharmacology
  • Camptothecin / therapeutic use
  • Clinical Trials, Phase I as Topic
  • Drug Design
  • Drug Synergism
  • Humans
  • Irinotecan
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasms / drug therapy*
  • Neoplasms / enzymology
  • Topoisomerase I Inhibitors*
  • Topotecan

Substances

  • Antineoplastic Agents, Phytogenic
  • Neoplasm Proteins
  • Topoisomerase I Inhibitors
  • Irinotecan
  • Topotecan
  • Camptothecin